ANVS vs CB · $80.4M cap vs P/E 14, rev $59.40B
Annovis Bio Inc (ANVS) versus Chubb Ltd (CB) — a side-by-side from cached financials, not a winner call.
Annovis Bio Inc (ANVS) is a biotechnology company listed on US.
Chubb Ltd (CB) is a insurance - property & casualty company listed on US.
Latest reported ANVS revenue for 2024-12-31 was $0. Net income was -$24.6M. ANVS currently screens at market cap $80.4M.
Latest reported CB revenue for 2025-12-31 was $59.40B. Net income was $10.31B. Revenue was up 6.5% from 2024-12-31 to 2025-12-31. CB currently screens at market cap $114.26B and trailing P/E 13.7.
ANVS currently screens at market cap $80.4M. CB currently screens at market cap $114.26B and trailing P/E 13.7.
Not investment advice. Open the ANVS and CB stock pages for the full models.
Not investment advice.